Federal health regulators are bolstering warning labels on popular pain relievers like Advil and Aleve, adding new information about their risks of heart attack and stroke. The changes announced Thursday apply to so-called non-steroidal anti-inflammatory drugs, or NSAIDs, including over-the-counter medications like Aleve and Motrin as well as high-powered prescription drugs like Celebrex.